From genome to vaccine: In silico predictions, ex vivo verification

Vaccine

Volumn 19, Issue 31, 2001, Pages 4385-4395

  De Groot, Anne S ^a,b   Bosma, Andrew ^a   Chinai, Natasha ^a   Frost, Julie ^a   Jesdale, Bill M ^a   Gonzalez, Michael A ^a   Martin, William ^a,b   Saint Aubin, Caitlin ^a  

^a BROWN UNIVERSITY   (United States)

^b EpiVax Inc   (United States)

Author keywords

Bioinformatics; Genome; Vaccine

Indexed keywords

EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; PROTEIN; PROTEOME; VACCINE;

ALGORITHM; AMINO ACID SEQUENCE; ARTICLE; CELL LINE; COMPUTER PROGRAM; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; EPITOPE MAPPING; GENE SEQUENCE; GENETIC SCREENING; GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; INFORMATION SCIENCE; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

AIDS VACCINES; ANIMALS; COMPUTATIONAL BIOLOGY; GENOME, BACTERIAL; GENOME, VIRAL; HIV; HUMANS; MYCOBACTERIUM TUBERCULOSIS;

EID: 0035859982     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00145-1     Document Type: Article

References (54)

1. Allele-specific motifs revealed by sequencing of self-eptides eluted from MHC molecules
2. Exact prediction of a natural T cell epitope
3. The discovery of MHC restriction
4. HLA supertypes and supermotifs: A functional perspective on HLA polymorphism
5. Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells
6. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: Correlation with a cytotoxic T cell epitope
7. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells
8. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif
9. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side chains
10. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences
11. Prediction of MHC binding peptides using artificial neural networks
12. Flexible docking of peptides to class I major-histocompatibility - Complex receptors
13. Ranking potential binding peptides to MHC molecules by a computational threading approach
14. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions
15. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning
16. New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library
17. An empirical method for the prediction of T-cell epitopes
18. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
19. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge
20. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen
21. Reverse immunogenetics: From HLA-disease associations to vaccine candidates
22. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice
23. NYVAC Pf7: A poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria
24. A multivalent minigene vaccine, containing B cell, CTL, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen
25. Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation
26. DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity
27. The immunogenicity of single and combination DNA vaccines against tuberculosis
28. Toward a vaccine for AIDS: The emergence of immunobiology based vaccine development
29. HIV vaccines: Where we are and where we are going
30. HIV sequence database
31. HIV sequence database
32. T cell epitope mapping of the major secreted mycobacterial antigen 85 A in tuberculosis and leprosy
33. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of mycobacterium tuberculosis
34. Mapping of the delayed type hypersensitivity response to an epitope of secreted protein MPT 64 from Mycobacterium tuberculosis
35. Identification of T cell stimulatory peptides from the 38 KD protein of Mycobacterium tuberculosis
36. Deciphering the biology of Mycobacterium tuberculosis from the complete genome
37. Prediction of well-conserved HIV-1 ligands using a Matrix-based Algorithm, EpiMatrix
38. An interactive Web site providing MHC ligand predictions: Application to HIV research
39. Prediction of HIV peptide epitopes by a novel algorithm
40. Prediction and validation of HLA-B7 restricted CTL epitopes based on upon autologous HIV-1 sequences
41. HLA-A11 cytotoxic T lymphocyte epitopes in HIV-1 env subtype E
42. Maintaining the integrity of human immunodeficiency virus sequence databases
43. The emerging genetic diversity of HIV
44. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells
45. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily
46. An epitope-selective, transporter associated with antigen presentation (TAP) - 1/2-independent pathway and a more general TAP - 1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8 + CTL
47. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation
48. Empty MHC class I molecules come out in the cold
49. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes
50. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual
51. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites